AI-generated summary
The authors randomized 50 women with breast cancer-related lymphedema to active low level laser therapy or a disabled placebo laser for 12 weeks, measuring limb volume, shoulder mobility and grip strength. They report greater improvement in limb volume at 8 and 12 weeks and better shoulder mobility and grip strength in the active group, though the abstract's conclusion of effectiveness in about 93% of patients is stated by the authors.
- Participants
- 50
- Who or what was studied
- Women with breast cancer-related (post-mastectomy) lymphedema
- Wavelengths
- 904 nm
- Limits stated in the abstract
- The abstract reports a small sample of 50 women split into two groups of 25 and does not describe long-term follow-up.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 904 nm
- Power
- 5 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.